Credit: Getty Images A literature review of nonpharmacologic treatments for patients with schizophrenia and comparison recommendations in the 2020 American Psychiatric Association Practice (APA) ...

Medication is the default schizophrenia treatment; however, it may not address key symptoms like social and cognitive deficits. Group therapy may be a new, promising intervention.

Scientists say they have developed a breakthrough new blood test for schizophrenia -- a chronic brain disorder that often causes delusions, hallucinations and disorganized speech. Scientists say they ...

Difficulty completing everyday tasks. Failing memory. Unusually poor concentration. For many people living with schizophrenia, cognitive challenges are part of daily life. Alongside well-known ...

On Thursday, the FDA approved Bristol Myers Squibb & Co’s (NYSE:BMY) Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. Bristol-Myers added the ...

Neumora Therapeutics, Inc. has announced the initiation of a Phase 1 study for NMRA-861, a potent and selective positive allosteric modulator of the M4 muscarinic receptor, aimed at treating ...

Schizophrenia is generally a chronic and disabling mental illness. Pharmacological therapy, which is used for relief of acute psychotic episodes and prevention of subsequent relapse, is essential for ...

Scientists are using avatars to help schizophrenia patients confront their phobias. Read more on our companion blog, NewsFeed. For years therapists have used computer simulations to create a safe, ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

Social determinants of health impacting the treatment landscape for schizophrenia are discussed. John J. Miller, MD:Sandy, what are some of the health inequities or social determinants of health that ...